Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 176

1.

Programmed nanoparticles for combined immunomodulation, antigen presentation and tracking of immunotherapeutic cells.

Heo MB, Lim YT.

Biomaterials. 2014 Jan;35(1):590-600. doi: 10.1016/j.biomaterials.2013.10.009. Epub 2013 Oct 11.

PMID:
24125775
2.

Polymer nanoparticles for enhanced immune response: combined delivery of tumor antigen and small interference RNA for immunosuppressive gene to dendritic cells.

Heo MB, Cho MY, Lim YT.

Acta Biomater. 2014 May;10(5):2169-76. doi: 10.1016/j.actbio.2013.12.050. Epub 2014 Jan 4.

PMID:
24394635
3.

STAT3 silencing in dendritic cells by siRNA polyplexes encapsulated in PLGA nanoparticles for the modulation of anticancer immune response.

Alshamsan A, Haddadi A, Hamdy S, Samuel J, El-Kadi AO, Uluda─č H, Lavasanifar A.

Mol Pharm. 2010 Oct 4;7(5):1643-54. doi: 10.1021/mp100067u. Epub 2010 Sep 14.

PMID:
20804176
4.

Polymer nanoparticles for cross-presentation of exogenous antigens and enhanced cytotoxic T-lymphocyte immune response.

Song C, Noh YW, Lim YT.

Int J Nanomedicine. 2016 Aug 5;11:3753-64. doi: 10.2147/IJN.S110796. eCollection 2016.

5.

Simultaneous in vivo tracking of dendritic cells and priming of an antigen-specific immune response.

Noh YW, Jang YS, Ahn KJ, Lim YT, Chung BH.

Biomaterials. 2011 Sep;32(26):6254-63. doi: 10.1016/j.biomaterials.2011.05.013. Epub 2011 May 26.

PMID:
21620470
6.

Sequential delivery of an anticancer drug and combined immunomodulatory nanoparticles for efficient chemoimmunotherapy.

Heo MB, Kim SY, Yun WS, Lim YT.

Int J Nanomedicine. 2015 Sep 24;10:5981-92. doi: 10.2147/IJN.S90104. eCollection 2015.

7.

Toll-like receptor 3-induced immune response by poly(d,l-lactide-co-glycolide) nanoparticles for dendritic cell-based cancer immunotherapy.

Han HD, Byeon Y, Kang TH, Jung ID, Lee JW, Shin BC, Lee YJ, Sood AK, Park YM.

Int J Nanomedicine. 2016 Nov 2;11:5729-5742. eCollection 2016.

8.

Targeted antigen delivery to dendritic cell via functionalized alginate nanoparticles for cancer immunotherapy.

Zhang C, Shi G, Zhang J, Song H, Niu J, Shi S, Huang P, Wang Y, Wang W, Li C, Kong D.

J Control Release. 2017 Jun 28;256:170-181. doi: 10.1016/j.jconrel.2017.04.020. Epub 2017 Apr 13.

PMID:
28414151
9.

"Pathogen-mimicking" nanoparticles for vaccine delivery to dendritic cells.

Elamanchili P, Lutsiak CM, Hamdy S, Diwan M, Samuel J.

J Immunother. 2007 May-Jun;30(4):378-95.

PMID:
17457213
10.
11.

Functional characterization of biodegradable nanoparticles as antigen delivery system.

Petrizzo A, Conte C, Tagliamonte M, Napolitano M, Bifulco K, Carriero V, De Stradis A, Tornesello ML, Buonaguro FM, Quaglia F, Buonaguro L.

J Exp Clin Cancer Res. 2015 Oct 6;34:114. doi: 10.1186/s13046-015-0231-9.

13.

Nanoparticles built by self-assembly of amphiphilic gamma-PGA can deliver antigens to antigen-presenting cells with high efficiency: a new tumor-vaccine carrier for eliciting effector T cells.

Yoshikawa T, Okada N, Oda A, Matsuo K, Matsuo K, Kayamuro H, Ishii Y, Yoshinaga T, Akagi T, Akashi M, Nakagawa S.

Vaccine. 2008 Mar 4;26(10):1303-13. doi: 10.1016/j.vaccine.2007.12.037. Epub 2008 Jan 15.

PMID:
18255205
14.

Retrovirally transduced bone marrow-derived dendritic cells require CD4+ T cell help to elicit protective and therapeutic antitumor immunity.

De Veerman M, Heirman C, Van Meirvenne S, Devos S, Corthals J, Moser M, Thielemans K.

J Immunol. 1999 Jan 1;162(1):144-51.

15.

Modulation of gene expression related to Toll-like receptor signaling in dendritic cells by poly(gamma-glutamic acid) nanoparticles.

Hamasaki T, Uto T, Akagi T, Akashi M, Baba M.

Clin Vaccine Immunol. 2010 May;17(5):748-56. doi: 10.1128/CVI.00505-09. Epub 2010 Mar 10.

16.
17.

Development of a poly(d,l-lactic-co-glycolic acid) nanoparticle formulation of STAT3 inhibitor JSI-124: implication for cancer immunotherapy.

Molavi O, Mahmud A, Hamdy S, Hung RW, Lai R, Samuel J, Lavasanifar A.

Mol Pharm. 2010 Apr 5;7(2):364-74. doi: 10.1021/mp900145g.

PMID:
20030320
18.
19.

pH-Responsive Poly(D,L-lactic-co-glycolic acid) Nanoparticles with Rapid Antigen Release Behavior Promote Immune Response.

Liu Q, Chen X, Jia J, Zhang W, Yang T, Wang L, Ma G.

ACS Nano. 2015 May 26;9(5):4925-38. doi: 10.1021/nn5066793. Epub 2015 Apr 24.

PMID:
25898266
20.

Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.

Galea-Lauri J, Wells JW, Darling D, Harrison P, Farzaneh F.

Cancer Immunol Immunother. 2004 Nov;53(11):963-77. Epub 2004 May 14.

PMID:
15146294

Supplemental Content

Support Center